DHA but Not EPA Emulsions Preserve Neurological and Mitochondrial Function after Brain Hypoxia-Ischemia in Neonatal Mice

Autor: Zoya V. Niatsetskaya, Richard J. Deckelbaum, Iliyan Vlasakov, Hylde Zirpoli, Sergey A. Sosunov, Korapat Mayurasakorn, Vadim S. Ten, Jill J. Williams
Rok vydání: 2016
Předmět:
0301 basic medicine
Mitochondrial ROS
Critical Care and Emergency Medicine
genetic structures
lcsh:Medicine
Physiology
Mitochondrion
Pharmacology
medicine.disease_cause
Biochemistry
Mice
Cognition
Learning and Memory
0302 clinical medicine
Reflexes
Medicine and Health Sciences
Metabolites
Brain Damage
lcsh:Science
Energy-Producing Organelles
Trauma Medicine
Animal Management
Hyperoxia
chemistry.chemical_classification
Multidisciplinary
food and beverages
Agriculture
Mitochondria
3. Good health
Neuroprotective Agents
Neurology
Eicosapentaenoic Acid
Docosahexaenoic acid
Hypoxia-Ischemia
Brain

Emulsions
lipids (amino acids
peptides
and proteins)

Cellular Structures and Organelles
medicine.symptom
Research Article
Docosahexaenoic Acids
Brain damage
Bioenergetics
Neuroprotection
03 medical and health sciences
Memory
medicine
Animals
Long-Term Memory
Animal Performance
Reactive oxygen species
business.industry
lcsh:R
Biology and Life Sciences
Cell Biology
Mice
Inbred C57BL

Oxidative Stress
Metabolism
030104 developmental biology
chemistry
Reperfusion
Cognitive Science
Calcium
lcsh:Q
Reactive Oxygen Species
business
030217 neurology & neurosurgery
Oxidative stress
Neuroscience
Zdroj: PLoS ONE, Vol 11, Iss 8, p e0160870 (2016)
PLoS ONE
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0160870
Popis: Background and Purpose Treatment with triglyceride emulsions of docosahexaenoic acid (tri-DHA) protected neonatal mice against hypoxia-ischemia (HI) brain injury. The mechanism of this neuroprotection remains unclear. We hypothesized that administration of tri-DHA enriches HI-brains with DHA/DHA metabolites. This reduces Ca2+-induced mitochondrial membrane permeabilization and attenuates brain injury. Methods 10-day-old C57BL/6J mice following HI-brain injury received tri-DHA, tri-EPA or vehicle. At 4–5 hours of reperfusion, mitochondrial fatty acid composition and Ca2+ buffering capacity were analyzed. At 24 hours and at 8–9 weeks of recovery, oxidative injury, neurofunctional and neuropathological outcomes were evaluated. In vitro, hyperoxia-induced mitochondrial generation of reactive oxygen species (ROS) and Ca2+ buffering capacity were measured in the presence or absence of DHA or EPA. Results Only post-treatment with tri-DHA reduced oxidative damage and improved short- and long-term neurological outcomes. This was associated with increased content of DHA in brain mitochondria and DHA-derived bioactive metabolites in cerebral tissue. After tri-DHA administration HI mitochondria were resistant to Ca2+-induced membrane permeabilization. In vitro, hyperoxia increased mitochondrial ROS production and reduced Ca2+ buffering capacity; DHA, but not EPA, significantly attenuated these effects of hyperoxia. Conclusions Post-treatment with tri-DHA resulted in significant accumulation of DHA and DHA derived bioactive metabolites in the HI-brain. This was associated with improved mitochondrial tolerance to Ca2+-induced permeabilization, reduced oxidative brain injury and permanent neuroprotection. Interaction of DHA with mitochondria alters ROS release and improves Ca2+ buffering capacity. This may account for neuroprotective action of post-HI administration of tri-DHA.
Databáze: OpenAIRE